News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
ProPetro, Patterson-UTI, and HighPeak Energy Stocks Trade Up, What You Need To Know What Happened? A number of stocks jumped in the afternoon session after Iran ruled out extending a 60-day memorandum of understanding with the United States. The June 17 memorandum was meant …
Sharemaestro market context Price below Trend Line 52 weeks +145.9% · Next-week setup negative 41.9%On Monday, Occidental Petroleum Corp. (OXY) shares rose by 1.17% to $59.04, marking its second consecutive day of gains. Despite this increase, the stock underperformed compared to its competitors as the broader market saw a decline, with the S&P 500 Index and Dow Jones …
This document from Neumora Therapeutics is a Notice of Proposed Sale of Securities pursuant to Rule 144. It indicates that the company is reporting on the intended sale of restricted or control securities as required by SEC regulations.
This article details Fidelity Advisor Mid Cap II Fund's historical holdings in Penumbra Inc (PEN). As of March 31, 2026, the fund held no shares, having made three purchases and two sales of the stock since 2025Q1. Despite currently holding no shares, the fund …
Avalo Therapeutics insider Mittie Doyle has filed a Form 144, indicating an intention to sell 5,037 shares of common stock on August 17, 2026, valued at $98,674.83, tied to the exercise of stock options. The filing also details several prior Rule 10b5-1 sales of …
Stoke Therapeutics announced that its Phase III EMPEROR study for zorevunersen in Dravet syndrome has surpassed its enrollment target with 162 patients and zero dropouts, attributing the high retention to the drug's tolerability and an open-label extension. The trial's primary endpoint is seizure reduction …
Petrobras is weighing whether to grant improved payment terms to Braskem on some contracts as the petrochemical producer races to find a solution for its debt woes ahead of an August 24 deadline to avoid bankruptcy protection, Bloomberg News reported Monday, citing people Silver …
Penumbra, Inc. (NYSE: PEN) is a leading medical device company with a $12.88 billion market capitalization, known for its thrombectomy systems and neurovascular products. The company shows strong revenue growth of 14.90% and a 11.37% Return on Equity, positioning it as an attractive investment …
Axsome Therapeutics (AXSM) is under scrutiny after reporting mixed Q2 2026 earnings, with increased revenue but also wider net losses. Despite a recent pullback, the stock shows strong long-term momentum, and analysts currently value it at $282.51 per share, suggesting it is undervalued compared …
Plains All American Pipeline LP's Chairman & CEO, Willie CW Chiang, exercised 346,357 Phantom Units into Common Units on August 14, 2026, with 136,292 Common Units withheld for tax liabilities. Concurrently, on August 13, 2026, he received a new grant of 373,000 Phantom Units …
Plains All American (NYSE: PAA) executive Jeremy L. Goebel reported multiple equity-compensation transactions, including exercising 640,691 Phantom Units, withholding 252,112 Common Units for taxes, and gifting 388,579 Common Units to a family limited partnership on August 14, 2026. This resulted in the family partnership …
PepsiCo (PEP) stock fell 1.82% while the broader S&P 500, Dow, and Nasdaq experienced smaller losses. Despite this daily dip, PepsiCo's shares had outperformed the Consumer Staples sector over the past month. Investors are looking forward to its upcoming earnings report, where analysts project …
Halozyme Therapeutics insider Helen Torley has filed a Form 144, indicating a proposed sale of 240,000 shares of common stock with an aggregate market value of $23,678,400. This follows previous sales by Torley totaling 51,923 shares over the past three months, generating over $3.5 …
An insider at Marathon Petroleum Corporation recently sold shares valued at $875,000, as reported in a recent SEC filing. This transaction occurred on August 17, 2026. The article also mentions recent analyst rating adjustments and other company news, including potential merger talks with Phillips …
Expedia Group Director Craig Jacobson sold 3,133 shares of the company's stock on August 13th for approximately $1.03 million, reducing his direct holdings by 9.5%. The sale occurred after Expedia reported better-than-expected quarterly results, with EPS of $5.76 and revenue of $4.32 billion. Analysts …
Scott Bizily plans to sell 6,540 shares of 4D Molecular Therapeutics (NASDAQ: FDMT) on August 17, 2026, following the exercise of stock options. This transaction, processed through Morgan Stanley Smith Barney LLC, has an associated value of $79,722.60. The filing also details three previous …
Scott Bizily, Chief Legal Officer of 4D Molecular Therapeutics (FDMT), sold 3,270 shares of common stock after exercising options. The transactions occurred on August 13 and August 17, 2026, with sales at $12.00 and $12.20 per share, respectively, and were executed under a Rule …
Neumora Therapeutics, Inc. has filed a Form 144 notice indicating a proposed sale of 146,706 common shares through Merrill Lynch, valued at approximately $220,135.18. The shares are expected to be sold on or about August 17, 2026, on the NASDAQ. These shares were acquired …
Pentair PLC (PNR) shares dropped 3.11% on Monday, closing at $64.10, underperforming the broader market. This decline occurred during a tough trading session where both the S&P 500 Index and Dow Jones Industrial Average also fell. This marks the second consecutive day of losses …
Marathon Petroleum Corp (MPC) Senior Vice President Shawn M. Lyon sold 2,500 shares of common stock at $350.00 per share on August 13, 2026, totaling $875,000. Following the transaction, Lyon directly holds 12,619 MPC shares and indirectly holds 2,938.762 shares through a 401(k) plan. …
Essex Property Trust Inc. (ESS) shares fell by 1.55% on Monday to $283.06, ending a two-day winning streak, despite an overall dismal trading session for the stock market. This decline occurred while the S&P 500 Index and Dow Jones Industrial Average also experienced losses.
Search by ticker symbol or company name and select a result to open its chart.